Cytomegalovirus seropositivity is associated with the expansion of CD4+CD28- and CD8+CD28- T cells in rheumatoid arthritis

Journal of Rheumatology

Volumn 26, Issue 7, 1999, Pages 1452-1457

  Hooper, Michele ^a   Kallas, Esper G ^a   Coffin, Denise ^a   Campbell, Deborah ^a   Evans, Thomas G ^a   Looney, R John ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b Rheumatology Unit   (United States)

Author keywords

CD28; CD57; Cytomegalovirus; Rheumatoid arthritis; T lymphocytes

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; SUPERANTIGEN;

ADULT; ARTICLE; CELL SPECIFICITY; CLINICAL ARTICLE; CYTOMEGALOVIRUS; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE MUTATION; HUMAN; HYPOTHESIS; MALE; PHENOTYPE; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

ANTIGENS, CD28; ARTHRITIS, RHEUMATOID; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; SEROLOGIC TESTS; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTE SUBSETS;

EID: 0033013522     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Bessis N, Chiocchia G, Kollias G, et al. Modulation of proinflammatory cytokine production in tumor necrosis factor-alpha-transgenic mice by treatment with cells engineered to secrete IL-4, IL-10 or IL-13. Clin Exp Immunol 1998;111:391-6.
2. Moreland LW, Baumgartner SW, Schiff MH, et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein [see comments]. N Engl J Med 1997;337:141-7.
3. Weyand CM, Hicok KC, Conn DL, Goronzy JJ. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis [see comments]. Ann Intern Med 1992;117:801-6.
4. Weyand CM, Xie C, Goronzy JJ. Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. J Clin Invest 1992;89:2033-9.
5. Jefferis R. Rheumatoid factors, B cells and immunoglobulin genes. Br Med Bull 1995;51:312-31.
6. Tugwell P, Pincus T, Yocum D, et al. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group [see comments]. N Engl J Med 1995;333:137-41.
7. Jendro MC, Ganten T, Matteson EL, Weyand CM, Goronzy JJ. Emergence of oligoclonal T cell populations following therapeutic T cell depletion in rheumatoid arthritis. Arthritis Rheum 1995;38:1242-51.
8. Kato T, Kurokawa M, Masuko-Hongo K, et al. T cell clonality in synovial fluid of a patient with rheumatoid arthritis: persistent but fluctuant oligoclonal T cell expansions. J Immunol 1997;159: 5143-9.
9. Schmidt D, Martens PB, Weyand CM, Goronzy JJ. The repertoire of CD4+ CD28-T cells in rheumatoid arthritis. J Mol Med 1996;2:608-18.
10. Waase I, Kayser C, Carlson PJ, Goronzy JJ, Weyand CM. Oligoclonal T cell proliferation in patients with rheumatoid arthritis and their unaffected siblings. Arthritis Rheum 1996;39:904-13.
11. Davey MP, Burgoine GA, Woody CN. TCRB clonotypes are present in CD4+ T cell populations prepared directly from rheumatoid synovium. Hum Immunol 1997;55:11-21.
12. Gonzalez-Quintial R, Baccala R, Pope RM, Theofilopoulos AN. Identification of clonally expanded T cells in rheumatoid arthritis using a sequence enrichment nuclease assay. J Clin Invest 1996;97:1335-43.
13. Ikeda Y, Masuko K, Nakai Y, et al. High frequencies of identical T cell clonotypes in synovial tissues of rheumatoid arthritis patients suggest the occurrence of common antigen-driven immune responses. Arthritis Rheum 1996;39:446-53.
14. Imberti L, Sottini A, Signorini S, Gorla R, Primi D. Oligoclonal CD4+ CD57+ T-cell expansions contribute to the imbalanced T-cell receptor repertoire of rheumatoid arthritis patients. Blood 1997;89:2822-32.
15. Breedveld FC, Struyk L, van Laar JM, Miltenburg AM, de Vries RR, van den Elsen PJ. Therapeutic regulation of T cells in rheumatoid arthritis, Immunol Rev 1995;144:5-16.
16. Martens PB, Goronzy JJ, Schaid D, Weyand CM. Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. Arthritis Rheum 1997;40:1106-14.
17. Schmidt D, Martens PB, Weyand CM, Goronzy JJ. The repertoire of CD4+ CD28-T cells in rheumatoid arthritis. J Mol Med 1996;2:608-18.
18. Schmidt D, Goronzy JJ, Weyand CM. CD4+ CD7-CD28-T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 1996;97:2027-37.
19. Choremi-Papadopoulou H, Viglis V, Gargalianos P, Kordossis T, Iniotaki-Theodoraki A, Kosmidis J. Downregulation of CD28 surface antigen on CD4+ and CD8+ T lymphocytes during HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 1994;7:245-53.
20. Hazzan M, Labalette M, Noel C, Lelievre G, Dessaint JP. Recall response to cytomegalovirus in allograft recipients: mobilization of CD57+, CD28+ cells before expansion of CD57+, CD28-cells within the CD8+ T lymphocyte compartment. Transplantation 1997;63:693-8.
21. Gratama JW, Naipal AM, Oosterveer MA, et al. Effects of herpes virus carrier status on peripheral T lymphocyte subsets. Blood 1987;70:516-23.
22. Gratama JW, Kardol M, Naipal AM, et al. The influence of cytomegalovirus carrier status on lymphocyte subsets and natural immunity. Clin Exp Immunol 1987;69:16-24.
23. Gratama JW, Kluin-Nelemans HC, Langelaar RA, et al. Flow cytometric and morphologic studies of HNK1+ (Leu 7+) lymphocytes in relation to cytomegalovirus carrier status. Clin Exp Immunol 1988;74:190-5.
24. Gratama JW, Langelaar RA, Oosterveer MA, et al. Phenotypic study of CD4+ and CD8+ lymphocyte subsets in relation to cylomegalovirus carrier status and its correlate with pokeweed mitogen-induced B lymphocyte differentiation. Clin Exp Immunol 1989;77:245-51.
25. Wang EC, Taylor-Wiedeman J, Perera P, Fisher J, Borysiewicz LK. Subsets of CD8+, CD57+ cells in normal, healthy individuals: correlations with human cytomegalovirus carrier status, phenotypic and functional analyses. Clin Exp Immunol 1993;94:297-305.
26. Wang EC, Lehner PJ, Graham S, Borysiewicz LK. CD8high (CD57+) T cells in normal, healthy individuals specifically suppress the generation of cytotoxic T lymphocytes to Epstein-Barr virus-transformed B cell lines. Eur J Immunol 1994;24:2903-9.
27. Wang EC, Moss PA, Frodsham P, Lehner PJ, Bell JI, Borysiewicz LK. CD8highCD57+ T lymphocytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus. J Immunol 1995;155:5046-56.
28. Wang EC, Borysiewicz LK. The role of CD8+, CD57+ cells in human cytomegalovirus and other viral infections. Scand J Infect Dis Suppl 1995;99:69-77.
29. Lenkei R, Andersson B. High correlations of anti-CMV titers with lymphocyte activation status and CD57 antibody-binding capacity as estimated with three-color, quantitative flow cytometry in blood donors. Clin Immunol Immunopathol 1995;77:131-8.
30. Mendelson M, Monard S, Sissons P, Sinclair J. Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. J Gen Virol 1996;77:3099-102.
31. Damle NK, Mohagheghpour N, Hansen JA, Engleman EG. Alloantigen-specific cytotoxic and suppressor T lymphocytes are derived from phenotypically distinct precursors. J Immunol 1983;131:2296-300.
32. Callan MF, Tan L, Annels N, et al. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med 1998;187:1395-402.
33. McMichael AJ, O'Callaghan CA. A new look at T cells. J Exp Med 1998;187:1367-71.
34. Gallimore A, Glithero A, Godkin A, et al. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J Exp Med 1998;187:1383-93.